BXM Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
5,430
+1,152
+27% +$268K 0.75% 31
2026
Q1
$1.05M Sell
4,278
-67,962
-94% -$15.8M 0.8% 30
2025
Q4
$817K Buy
72,240
+67,298
+1,362% +$13.3M 0.63% 43
2025
Q3
$916K Buy
4,942
+1,260
+34% +$216K 0.87% 29
2025
Q2
$572K Sell
3,682
-1,219
-25% -$187K 0.68% 48
2025
Q1
$809K Sell
4,901
-625
-11% -$97.8K 0.97% 29
2024
Q4
$799K Buy
+5,526
New +$856K 1.12% 26

Other funds holding JNJ

BXM Wealth's JNJ Position: Q2 2026 in Review

BXM Wealth increased its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, buying an estimated $268K and bringing the position to 5,430 shares worth $1.38M. The position accounts for 0.75% of the portfolio, ranked #31.

BXM Wealth first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 1,694 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BXM Wealth held 5,430 shares of Johnson & Johnson worth $1.38M as of Q2 2026.
  • BXM Wealth bought 1,152 Johnson & Johnson shares in Q2 2026, an estimated $268K.
  • Johnson & Johnson made up 0.75% of BXM Wealth's portfolio in Q2 2026, its #31 holding.
  • BXM Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.